Abstract: | L-Arginine (L-Arg) affects variousparameters that modulate the progression of renal disease. These samefactors [e.g., glomerular filtration rate, changes in mesangialcell (MC) tension, and production of NO] are all controlled atleast in part by changes in MC intracellular Ca2+concentration([Ca2+]i). Wetherefore evaluated the effect of L-Arg on MC[Ca2+]i. We found thatL-Arg inhibits the vasopressin-stimulated rise in MC[Ca2+]i both in rat andmurine cell cultures. This effect does not appear to be due tometabolism of L-Arg to either NO or L-ornithine (L-Orn). Blocking the metabolism of L-Arg withN-monomethyl-L-arginine, an NOsynthase inhibitor, or with 20 mM L-valine(L-Val), an inhibitor of Orn formation,does not reverse the inhibition. However, other cationic amino acids,as well guanidine, the functional group ofL-Arg, all inhibit thevasopressin-stimulated rise in[Ca2+]i,consistent with a structural basis for this effect. We conclude that1)L-Arg inhibitsvasopressin-stimulated murine and rat MC [Ca2+]irise, 2) this inhibition is notmediated by metabolism of L-Arg to either NO or L-Orn, and3) the effect ofL-Arg is due to its cationicfunctional group, guanidine. |